Techno Electric & Engineering Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 4:13 am

Competitors of Techno Electric & Engineering Company Ltd

All Competitor Stocks of Techno Electric & Engineering Company Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:35 am

Below is a detailed analysis of the quarterly data for Techno Electric & Engineering Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 526.00 Cr.. The value appears to be declining and may need further review. It has decreased from 816.00 Cr. (Mar 2025) to 526.00 Cr., marking a decrease of 290.00 Cr..
• For Expenses, as of Jun 2025, the value is 434.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 689.00 Cr. (Mar 2025) to 434.00 Cr., marking a decrease of 255.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 92.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Mar 2025) to 92.00 Cr., marking a decrease of 35.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Mar 2025) to 18.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 20.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 161.00 Cr.. The value appears to be declining and may need further review. It has decreased from 174.00 Cr. (Mar 2025) to 161.00 Cr., marking a decrease of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 23.00% (Mar 2025) to 16.00%, marking a decrease of 7.00%.
• For Net Profit, as of Jun 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2025) to 136.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 11.70. The value appears strong and on an upward trend. It has increased from 11.58 (Mar 2025) to 11.70, marking an increase of 0.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:18 am

Growth

Last Updated: September 5, 2025, 1:41 pm

Balance Sheet

Last Updated: September 10, 2025, 2:38 pm

Below is a detailed analysis of the balance sheet data for Techno Electric & Engineering Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,716.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,142.00 Cr. (Mar 2024) to 3,716.00 Cr., marking an increase of 1,574.00 Cr..
• For Borrowings, as of Mar 2025, the value is 39.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 39.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,265.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 658.00 Cr. (Mar 2024) to 1,265.00 Cr., marking an increase of 607.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,044.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,821.00 Cr. (Mar 2024) to 5,044.00 Cr., marking an increase of 2,223.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Mar 2024) to 70.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 442.00 Cr.. The value appears strong and on an upward trend. It has increased from 276.00 Cr. (Mar 2024) to 442.00 Cr., marking an increase of 166.00 Cr..
• For Investments, as of Mar 2025, the value is 2,836.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,142.00 Cr. (Mar 2024) to 2,836.00 Cr., marking an increase of 1,694.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,696.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,327.00 Cr. (Mar 2024) to 1,696.00 Cr., marking an increase of 369.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,044.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,821.00 Cr. (Mar 2024) to 5,044.00 Cr., marking an increase of 2,223.00 Cr..

Notably, the Reserves (3,716.00 Cr.) exceed the Borrowings (39.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Techno Electric & Engineering Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 37.19. This value is within the healthy range. It has increased from 24.94 (Mar 24) to 37.19, marking an increase of 12.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 37.19. This value is within the healthy range. It has increased from 24.94 (Mar 24) to 37.19, marking an increase of 12.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 37.06. This value is within the healthy range. It has increased from 25.67 (Mar 24) to 37.06, marking an increase of 11.39.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 321.55. It has increased from 201.01 (Mar 24) to 321.55, marking an increase of 120.54.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 321.55. It has increased from 201.01 (Mar 24) to 321.55, marking an increase of 120.54.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 195.07. It has increased from 139.60 (Mar 24) to 195.07, marking an increase of 55.47.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 42.92. This value is within the healthy range. It has increased from 32.11 (Mar 24) to 42.92, marking an increase of 10.81.
• For PBIT / Share (Rs.), as of Mar 25, the value is 42.23. This value is within the healthy range. It has increased from 31.38 (Mar 24) to 42.23, marking an increase of 10.85.
• For PBT / Share (Rs.), as of Mar 25, the value is 41.33. This value is within the healthy range. It has increased from 29.85 (Mar 24) to 41.33, marking an increase of 11.48.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 24.94 (Mar 24) to 36.37, marking an increase of 11.43.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 24.95 (Mar 24) to 36.37, marking an increase of 11.42.
• For PBDIT Margin (%), as of Mar 25, the value is 22.00. This value is within the healthy range. It has decreased from 22.99 (Mar 24) to 22.00, marking a decrease of 0.99.
• For PBIT Margin (%), as of Mar 25, the value is 21.64. This value exceeds the healthy maximum of 20. It has decreased from 22.47 (Mar 24) to 21.64, marking a decrease of 0.83.
• For PBT Margin (%), as of Mar 25, the value is 21.18. This value is within the healthy range. It has decreased from 21.38 (Mar 24) to 21.18, marking a decrease of 0.20.
• For Net Profit Margin (%), as of Mar 25, the value is 18.64. This value exceeds the healthy maximum of 10. It has increased from 17.86 (Mar 24) to 18.64, marking an increase of 0.78.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.64. This value is within the healthy range. It has increased from 17.86 (Mar 24) to 18.64, marking an increase of 0.78.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.30. This value is below the healthy minimum of 15. It has decreased from 12.41 (Mar 24) to 11.30, marking a decrease of 1.11.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 11.95, marking a decrease of 2.93.
• For Return On Assets (%), as of Mar 25, the value is 8.36. This value is within the healthy range. It has decreased from 9.47 (Mar 24) to 8.36, marking a decrease of 1.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has increased from 0.53 (Mar 24) to 0.57, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 4.70. This value exceeds the healthy maximum of 3. It has increased from 4.30 (Mar 24) to 4.70, marking an increase of 0.40.
• For Quick Ratio (X), as of Mar 25, the value is 4.70. This value exceeds the healthy maximum of 2. It has increased from 4.25 (Mar 24) to 4.70, marking an increase of 0.45.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 175.52. This value exceeds the healthy maximum of 8. It has increased from 23.68 (Mar 24) to 175.52, marking an increase of 151.84.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.24. This value is below the healthy minimum of 20. It has decreased from 24.05 (Mar 24) to 19.24, marking a decrease of 4.81.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.88. This value is below the healthy minimum of 20. It has decreased from 23.37 (Mar 24) to 18.88, marking a decrease of 4.49.
• For Earning Retention Ratio (%), as of Mar 25, the value is 80.76. This value exceeds the healthy maximum of 70. It has increased from 75.95 (Mar 24) to 80.76, marking an increase of 4.81.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.12. This value exceeds the healthy maximum of 70. It has increased from 76.63 (Mar 24) to 81.12, marking an increase of 4.49.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 47.40. This value is within the healthy range. It has increased from 21.03 (Mar 24) to 47.40, marking an increase of 26.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.90. This value is within the healthy range. It has increased from 17.50 (Mar 24) to 36.90, marking an increase of 19.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 11,573.47. It has increased from 8,161.34 (Mar 24) to 11,573.47, marking an increase of 3,412.13.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.10. This value exceeds the healthy maximum of 3. It has decreased from 5.43 (Mar 24) to 5.10, marking a decrease of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 23.18. This value exceeds the healthy maximum of 15. It has decreased from 23.62 (Mar 24) to 23.18, marking a decrease of 0.44.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 3. It has decreased from 5.52 (Mar 24) to 5.14, marking a decrease of 0.38.
• For Retention Ratios (%), as of Mar 25, the value is 80.75. This value exceeds the healthy maximum of 70. It has increased from 75.94 (Mar 24) to 80.75, marking an increase of 4.81.
• For Price / BV (X), as of Mar 25, the value is 3.12. This value exceeds the healthy maximum of 3. It has decreased from 3.84 (Mar 24) to 3.12, marking a decrease of 0.72.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 3. It has decreased from 5.52 (Mar 24) to 5.14, marking a decrease of 0.38.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness